Seroconversion Rate After SARS-CoV-2 Infection and Two Doses of Either ChAdOx1-nCOV COVISHIELD™ or BBV-152 COVAXIN™ Vaccination in Renal Allograft Recipients: An Experience of Two Public and Private Tertiary Care Center
SARS-CoV-2感染后,肾移植受者接种两剂ChAdOx1-nCOV COVISHIELD™或BBV-152 COVAXIN™疫苗后的血清转化率:两家公立和私立三级医疗中心的经验
期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2022.911738
Prasad, Narayan; Bansal, Shyam Bihari; Yadav, Brijesh; Manhas, Neha; Yadav, Deependra; Gautam, Sonam; Kushwaha, Ravishankar; Singh, Ankita; Bhadauria, Dharmendra; Yachha, Monika; Behera, Manas Ranjan; Kaul, Anupama